These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29306659)

  • 1. Breast Osteoblast-like Cells: A Reliable Early Marker for Bone Metastases From Breast Cancer.
    Scimeca M; Antonacci C; Toschi N; Giannini E; Bonfiglio R; Buonomo CO; Pistolese CA; Tarantino U; Bonanno E
    Clin Breast Cancer; 2018 Aug; 18(4):e659-e669. PubMed ID: 29306659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblast-like cells in human cancers: new cell type and reliable markers for bone metastasis.
    Scimeca M; Bonfiglio R; Montanaro M; Bonanno E
    Future Oncol; 2018 Jan; 14(1):9-11. PubMed ID: 29219614
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast osteoblast-like cells: a new biomarker for the management of breast cancer.
    Scimeca M; Urbano N; Bonfiglio R; Schillaci O; Bonanno E
    Br J Cancer; 2018 Oct; 119(9):1129-1132. PubMed ID: 30327566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
    Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
    Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer metastasis to bone: From epithelial to mesenchymal transition to breast osteoblast-like cells.
    Scimeca M; Trivigno D; Bonfiglio R; Ciuffa S; Urbano N; Schillaci O; Bonanno E
    Semin Cancer Biol; 2021 Jul; 72():155-164. PubMed ID: 32045651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the mechanisms of osteolysis in patients with metastatic breast cancer.
    Trinkaus M; Ooi WS; Amir E; Popovic S; Kalina M; Kahn H; Singh G; Gainford MC; Clemons M
    Oncol Rep; 2009 May; 21(5):1153-9. PubMed ID: 19360288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Location matters: osteoblast and osteoclast distribution is modified by the presence and proximity to breast cancer cells in vivo.
    Brown HK; Ottewell PD; Evans CA; Holen I
    Clin Exp Metastasis; 2012 Dec; 29(8):927-38. PubMed ID: 22562502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.
    Kolb AD; Shupp AB; Mukhopadhyay D; Marini FC; Bussard KM
    Breast Cancer Res; 2019 Feb; 21(1):31. PubMed ID: 30813947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment.
    Haider MT; Saito H; Zarrer J; Uzhunnumpuram K; Nagarajan S; Kari V; Horn-Glander M; Werner S; Hesse E; Taipaleenmäki H
    Breast Cancer Res; 2020 Apr; 22(1):34. PubMed ID: 32272947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer metastasis to the bone: mechanisms of bone loss.
    Chen YC; Sosnoski DM; Mastro AM
    Breast Cancer Res; 2010; 12(6):215. PubMed ID: 21176175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Molecular View of Pathological Microcalcification in Breast Cancer.
    Sharma T; Radosevich JA; Pachori G; Mandal CC
    J Mammary Gland Biol Neoplasia; 2016 Jun; 21(1-2):25-40. PubMed ID: 26769216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcalcifications Drive Breast Cancer Occurrence and Development by Macrophage-Mediated Epithelial to Mesenchymal Transition.
    Scimeca M; Bonfiglio R; Menichini E; Albonici L; Urbano N; De Caro MT; Mauriello A; Schillaci O; Gambacurta A; Bonanno E
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31718020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways.
    Zheng Y; Chow SO; Boernert K; Basel D; Mikuscheva A; Kim S; Fong-Yee C; Trivedi T; Buttgereit F; Sutherland RL; Dunstan CR; Zhou H; Seibel MJ
    J Bone Miner Res; 2014 Sep; 29(9):1938-49. PubMed ID: 24676805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
    Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function.
    Choi B; Lee EJ; Song DH; Yoon SC; Chung YH; Jang Y; Kim SM; Song Y; Kang SW; Yoon SY; Chang EJ
    Oncotarget; 2014 Jan; 5(2):481-92. PubMed ID: 24457902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP-2 Variants in Breast Epithelial to Mesenchymal Transition and Microcalcifications Origin.
    Scimeca M; Giocondo R; Montanaro M; Granaglia A; Bonfiglio R; Tancredi V; Mauriello A; Urbano N; Schillaci O; Bonanno E
    Cells; 2020 Jun; 9(6):. PubMed ID: 32498363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
    Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
    Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives.
    Infante M; Fabi A; Cognetti F; Gorini S; Caprio M; Fabbri A
    J Exp Clin Cancer Res; 2019 Jan; 38(1):12. PubMed ID: 30621730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients.
    Ibrahim T; Sacanna E; Gaudio M; Mercatali L; Scarpi E; Zoli W; Serra P; Ricci R; Serra L; Kang Y; Amadori D
    Clin Breast Cancer; 2011 Dec; 11(6):369-75. PubMed ID: 21764390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.